This article has some useful information but, of course, cannot openly tell their readers that this is truly valuable so they have to attack it somehow. If you are not taking ACS 200 yourself, maybe you do not believe that it has germ killing powers?

I believe that infections are part of our current health crisis! I believe that it is well proven that we have organisms in the mouth that are difficult to identify and dangerous when they make their way into the systemic circulation, which they ALWAYS manage to do. I hold my ACS 200 in the mouth at least a minute 2-3 times a day. I think that lowering my total body burden of infections is just as useful for optimizing my health as lowering my burden of other toxins, like heavy metals.

Your patients may be confused by this article so take a moment to see it lacks clarity and even contradicts itself. Read more...

Lose weight quick

(HealthDay News) -- Positive brain changes take hold after just 11 hours of practicing a form of meditation, the results of a new study suggest.

The study included 45 University of Oregon students who were randomly selected to be in either a study group that did integrative body-mind training (IBMT) or a control group that did relaxation training. IBMT was adapted from traditional Chinese medicine in the 1990s.

A comparison of scans taken of the students' brains before and after the training showed that those in the IBMT group had increased brain connectivity. The changes were strongest in connections involving the anterior cingulate, an area that plays a role in the regulation of emotions and behavior, Yi-Yuan Tang of Dalian University of Technology in China, University of Oregon psychologist Michael I. Posner, and colleagues found.

The boost in brain connectivity began after six hours of IBMT and became more apparent after 11 hours of practice, according to the report published in the Aug. 16-21 online edition of the Proceedings of the National Academy of Sciences. Read more...

Memory concentration, loss of memory

Meat allergies may be much more common than previously thought and may even induce potentially fatal anaphylaxis in some people, according to a study conducted by researchers from the University of Virginia and presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology in New Orleans.

The researchers tested three groups of people across the U.S. Southeast with a history of recurrent anaphylaxis without known cause for an immune reaction to alpha-gal, a kind of sugar found in mammal meat.

Although most allergic reactions are caused by proteins, scientists recently discovered that alpha-gal is responsible for anaphylactic reactions to cetuximab, a cancer drug. Further studies revealed that people who experience immune responses to alpha-gal also develop allergic symptoms within three to six hours of eating mammalian meat.

Alpha-gal is not found in the flesh of bird or fish.

The researchers found that between 20 and 50 percent of participants tested positive for allergy to alpha-gal. Overall, 25 of 60 participants (42 percent) showed signs of meat allergy. Read more...

Female Sexual health

In the past researchers have observed an association between poor mitochondrial function and Parkinson's disease, a neurodegenerative disorder of the central nervous system that impairs speech and motor functions and affects five million people worldwide. A new meta-analysis suggests that low expression levels of 10 related gene sets responsible for mitochondrial machinery play an important role in this disorder--all previously unlinked to Parkinson's. The study, published online today in Science Translational Medicine , further points to a master switch for these gene sets as a potential target of future therapies. [More]

Editor's Note: This is an expanded version of the Q&A that will appear in the November 2010 issue of Scientific American.

Name: Greg Graffin [More]

Greg Graffin - BadReligion - Punk rock - Punk - Shopping

Realistic stem cell therapies to replace diseased or damaged tissue may still be years away, but researchers have uncovered a promising new use for these undifferentiated cells: they can be programmed to become patient-specific laboratory models of inherited liver disease. These new tools could be useful for teasing out disease mechanisms and testing new drug therapies.

Scientists from the University of Cambridge's Institute for Medical Research obtained skin cells from 10 patients--seven who had various forms of inherited liver disease, and three healthy controls. They reprogrammed the skin cells, rejuvenating them into an embryolike state (using the four-gene approach described in 2007). The researchers then cultured these so-called induced pluripotent stem cells (iPS cells) in a mixture of chemical factors that triggered their conversion into liver cells, which had the appearance and functional properties of native liver cells.

[More]

Stem cell - Cambridge University - Liver - Medical Research - Disease

Product marketing teams look at the software buying cycle as a consistent series of steps: awareness, consideration, trial, purchase, implementation and renewal.   For years, these steps have been manipulated through solution selling  where the key to success is control.  By knowing the buyer, the steps and the product, a skilled selling team is able to control the process and predict favorable outcomes on a consistent basis.  Oracle, SAP and Mic … Read More

via Inner Lining

GE Healthcare announced that the Smart Patient Room pilot at Bassett Medical Center has been approved by the site’s Institutional Review Board to begin data collection. The innovative technology solution was installed as part of GE’s healthymagination initiative with the goal of helping healthcare providers to reduce patient safety risks and improve patient outcomes.

“GE is developing a unique solution for the healthcare industry that helps hospitals and staff identify and mitigate patient safety risks while offering meaningful solutions to improve patient outcomes,” said Jan De Witte, President & CEO, GE Healthcare Performance Solutions. “GE’s real-time, adaptable solution will provide actionable data to healthcare providers regarding patient safety and potential medical errors which in turn will affect the necessary behavioral changes to avoid preventable errors.”

The Smart Patient Room can collect real-time information from the system to generate actionable data to manage clinical workflow, and uncover opportunities for influencing process and behavioral changes to create a safer patient environment.

developers at Mount Sinai develop a New database and software, called ChEA which can speed up drug discovery at Mount Sinai develop a New database and software, called ChEA which can speed up drug discovery

The ChEA software and ChIP-X database is freely available online at:http://amp.pharm.mssm.edu/lib/chea.jsp.

until ChEA was developed, no centralized database integrated results from, for instance, ChIP-seq and ChIP-chip experiments (these are used to identify how “transcription factor” proteins might regulate all genes in humans and mice). Now this new computational method should help streamline how scientists analyze these gene expression experiments

Insights into the stem cells of chronic myeloid leukemia by I Sloma, X Jiang, A C Eaves and C J Eaves, Leukemia 2010(Sep 23). [Epub ahead of print][PubMed citation]. Abstract:

Chronic myeloid leukemia (CML) has long served as a paradigm for generating new insights into the cellular origin, pathogenesis and improved approaches to treating many types of human cancer. Early studies of the cellular phenotypes and genotypes represented in leukemic populations obtained from CML patients established the concept of an evolving clonal disorder originating in and initially sustained by a rare, multipotent, self-maintaining hematopoietic stem cell (HSC). More recent investigations continue to support this model, while also revealing new insights into the cellular and molecular mechanisms that explain how knowledge of CML stem cells and their early differentiating progeny can predict the differing and variable features of chronic phase and blast crisis. In particular, these emphasize the need for new agents that effectively and specifically target CML stem cells to produce non-toxic, but curative therapies that do not require lifelong treatments.

Critical molecular pathways in cancer stem cells of chronic myeloid leukemia by Y Chen, C Peng, C Sullivan, D Li and S Li, Leukemia 2010(Sep); 24(9): 1545-54. Epub 2010 Jun 24. [Connotea bookmark][PubMed citation][Full text]. The abstract of this OA review:

Inhibition of BCR-ABL with kinase inhibitors in the treatment of Philadelphia-positive (Ph(+)) chronic myeloid leukemia (CML) is highly effective in controlling but not curing the disease. This is largely due to the inability of these kinase inhibitors to kill leukemia stem cells (LSCs) responsible for disease relapse. This stem cell resistance is not associated with the BCR-ABL kinase domain mutations resistant to kinase inhibitors. Development of curative therapies for CML requires the identification of crucial molecular pathways responsible for the survival and self-renewal of LSCs. In this review, we will discuss our current understanding of these crucial molecular pathways in LSCs and the available therapeutic strategies for targeting these stem cells in CML.